Hi Ajostu,
You asked;
Do we know if there's an intrention or a nominal plan for a pediatric trial for Rett/2566 following the current phase II adult trial?
If you look at the May 2012 AGM CEO Presentation it highlights...
A second study in pediatric patients is planned for 2013. If the results of the Phase II trials are positive, we believe that a single pivotal trial in adolescents and adults and one in children would be required to submit an NDA for approval.
Regards,
Tony
Hi Ajostu,You asked;Do we know if there's an intrention or a...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.200(1.03%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.50 | $19.59 | $19.11 | $5.729M | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $19.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 640 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |